CIK 0001660334 · Non-accelerated filer<br>Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463137900
- Phone
- 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- Open-market buys, last 90 days
- $109,690
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$109,690. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-27 | Bonaccorso Joe CHIEF COMMERCIAL OFFICER | Sale | −8,993 | $2.46 | $22K | 73,114 |
| 2024-08-27 | Kohler Terry CHIEF FINANCIAL OFFICER | Sale | −7,899 | $2.46 | $19K | 44,697 |
| 2024-08-27 | White Ted PRESIDENT AND CEO | Sale | −9,021 | $2.46 | $22K | 215,967 |
| 2024-08-26 | Hayes Christopher G. CHIEF LEGAL OFFICER | Sale | −26,183 | $2.66 | $70K | 115,303 |
| 2024-08-26 | Goldenberg Gary Chief Medical Officer | Sale | −9,888 | $2.66 | $26K | 97,862 |
| 2024-08-26 | Bonaccorso Joe CHIEF COMMERCIAL OFFICER | Sale | −24,709 | $2.66 | $66K | 82,107 |
| 2024-08-26 | Kohler Terry CHIEF FINANCIAL OFFICER | Sale | −21,820 | $2.66 | $58K | 52,596 |
| 2024-08-26 | White Ted PRESIDENT AND CEO | Sale | −24,979 | $2.66 | $66K | 224,988 |
| 2024-07-23 | White Ted PRESIDENT AND CEO | Sale | −154 | $6.98 | $1K | 249,967 |
| 2024-07-23 | Bonaccorso Joe CHIEF COMMERCIAL OFFICER | Sale | −115 | $6.98 | $803 | 106,816 |
| 2024-07-23 | Goldenberg Gary Chief Medical Officer | Sale | −86 | $6.98 | $600 | 107,750 |
| 2024-07-23 | Hayes Christopher G. CHIEF LEGAL OFFICER | Sale | −91 | $6.98 | $635 | 141,486 |
| 2024-07-22 | White Ted PRESIDENT AND CEO | Sale | −32,469 | $7.06 | $229K | 250,121 |
| 2024-07-22 | Bonaccorso Joe CHIEF COMMERCIAL OFFICER | Sale | −25,461 | $7.06 | $180K | 106,931 |
| 2024-07-22 | Goldenberg Gary Chief Medical Officer | Sale | −18,421 | $7.06 | $130K | 107,836 |
| 2024-07-22 | Hayes Christopher G. CHIEF LEGAL OFFICER | Sale | −21,649 | $7.06 | $153K | 141,577 |
| 2024-06-06 | PRYGOCKI MARK A SR Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-06-06 | Nguyen Diem Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-06-06 | Eichenfield Lawrence Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-06-06 | Ballaron Craig Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 4 of 8 · 154 trades